Hangzhou Tigermed Consulting Co., Ltd. (3347.HK) HKSE

41.70

+1.06(+2.61%)

Updated at December 24 12:08PM

Currency In HKD

Hangzhou Tigermed Consulting Co., Ltd.

Address

F18, Building A – Shengda Science Park

Hangzhou, 310051

China

Phone

86 57 1288 87227

Sector

Healthcare

Industry

Medical - Diagnostics & Research

Employees

10185

First IPO Date

August 07, 2020

Key Executives

NameTitlePayYear Born
Tianrong JiChief Investment Officer0N/A
Xiaochun CaoCo-Founder, GM & Executive Director01969
Xiaoping Ye D.PhilCo-Founder & Chairman01963
Guoyun YuHead of Accounting Department0N/A
Hao WuPresident & Executive Director01967
Jiansong YangSenior Vice President & Chief Scientific Officer0N/A
Zengyu WenExecutive Vice President, Chief Operating Officer & Executive Director01980
Chengcheng YangChief Financial Officer01974
Mo ShuangChief Compliance Officer0N/A
Xiao Ri LiSecretary01983

Description

Hangzhou Tigermed Consulting Co., Ltd. provides contract research organization services in the People's Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers regulatory submission and approval, medical translation, and good manufacturing practice (GMP) consulting services; and clinical services in the areas of medical science, early clinical and late phase development, medical monitoring, project management, patient recruitment, and quality management system. It also provides biometrics services comprising data management, biostatistics, and statistical programming; and integrated technology services, such as site management, pharmacovigilance, third party audit and training, medical imaging, clinical trial system solution, central laboratory, pre-clinical, and research hospital. Further, the company offers medical device/ in vitro diagnostics (IVD) services comprising medical device testing, regulatory submission, clinical evaluation and trials, GMP certificate, EU MDR and IVDR preparation, and value-added services; and post-marketing study, real world evidence, and vaccine clinical trial services. Hangzhou Tigermed Consulting Co., Ltd. was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China.